Combined BRAFV600E- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer

Pierre Vanden Borre(Harvard University), Sareh Parangi(Harvard University)
Oncotarget
June 26, 2014
Cited by 43


Related Papers